Chongqing Genrix Biopharmaceutical Co., Ltd. Class ASSE: 688443

Announcement on Voluntary Closure of the Commercialization Cooperation for Vecantoxatug Monoclonal Antibody Injection and Silevimig Monoclonal Antibody Injection

· Issued by Chongqing Genrix Biopharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Voluntary Closure of the Commercialization Cooperation for Vecantoxatug Monoclonal Antibody Injection and Silevimig Monoclonal Antibody Injection

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment